Introduction Dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide 1 (GLP-1) receptor agonist
doi: 10.3390/cancers16040684, 6
CrossRef The emergent role of mitochondrial RNA modifications in metabolic alterations Hatim Boughanem, Yvonne Bttcher, Joo TomCarneiro, MaraCarmen Lpez de las Hazas, Alberto Dvalos, Akin Cayir, Manuel MaciasGonzlez WIREs RNA.2023;[Epub] CrossRef Ageassociated adipose tissue inflammation promotes monocyte chemotaxis and enhances atherosclerosis Jianrui Song, Diana Farris, Paola Ariza, Smriti Moorjani, Mita Varghese, Muriel Blin, Judy Chen, Daniel Tyrrell, Min Zhang, Kanakadurga Singer, Morgan Salmon, Daniel R
Combining Semaglutide with Lifestyle Changes While semaglutide can be a powerful tool for weight loss, it's not a magic solution
PMID: 2859987
The delayed gastric emptying induced by GLP-1 medications means food remains in the stomach for longer periods